Related Experiment Video
Updated: Oct 21, 2025
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.7K
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression
Focus (American Psychiatric Publishing)
|September 6, 2021
Summary
This study explored the impact of exercise on cognitive function in older adults. Results indicate that regular physical activity can significantly improve memory and executive function in the elderly.
Area of Science:
- Geriatric Psychiatry
- Neuroscience
- Exercise Science
Background:
- Cognitive decline is a significant concern in aging populations.
- The relationship between physical activity and cognitive health in older adults requires further investigation.
Purpose of the Study:
- To examine the effects of a structured exercise program on cognitive performance in elderly individuals.
- To identify specific cognitive domains that benefit from physical activity in this demographic.
Main Methods:
- Participants: 150 older adults (65+ years) with no diagnosed dementia.
- Intervention: 12-week moderate-intensity aerobic exercise program (3 times/week).
- Assessments: Standardized neuropsychological tests evaluating memory, attention, and executive function before and after the intervention.
Main Results:
- Significant improvements were observed in delayed recall (p<0.01) and executive function (p<0.05) in the exercise group compared to a control group.
- No significant changes were noted in attention or processing speed.
- Adherence to the exercise program was high (85%).
Conclusions:
- Regular moderate-intensity exercise can enhance specific cognitive functions, particularly memory and executive functions, in healthy older adults.
- Exercise interventions represent a promising non-pharmacological strategy for promoting cognitive vitality in aging.
- Further research should explore long-term effects and optimal exercise parameters.
More Related Videos
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
47
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
47
01:15Drug Dosing: Geriatric Patients
39
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
39
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
32
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
32
01:23Antidepressant Drugs: MAOIs and Other Agents
476
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
476
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
31
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
31
02:50Combination Therapies and Personalized Medicine
5.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K